stuff 🩷
رفتن به کانال در Telegram
اي شي عشوائي يفيد ✌️ اي شي تحبون تشاركوه مع او بدون اسم @dohayarub ادعوا لي و للادمن البنات بالتوفيق
نمایش بیشترالعراق72 735دسته بندی مشخص نشده است
498
مشترکین
+1024 ساعت
+537 روز
+6530 روز
آرشیو پست ها
498
Repost from Quiz-UOBCOM95
Which of the following statement is Not true regarding the modes of the escape of oncogenic cells from host defense mechanisms?
498
Repost from Quiz-UOBCOM95
The normal Immusological control of tumors is referred to ss:
498
Repost from Quiz-UOBCOM95
Macrophages can be eytotoxic for other cancer cells as a result of the release of:
498
🔹✅ Answer: B
⸻
🔹Q24. Rituximab was the first monoclonal antibody approved by the FDA for treatment of:
🔹A) Breast cancer
🔹B) Colorectal cancer
🔹C) Non-Hodgkin lymphoma
🔹D) Lung cancer
🔹✅ Answer: C
⸻
🔹Q25. Cetuximab (Erbitux) is used for treatment of:
🔹A) Colorectal cancer and head & neck cancers
🔹B) RA and SLE
🔹C) Breast cancer only
🔹D) Crohn disease
🔹✅ Answer: A
⸻
🔹Q26. Bevacizumab (Avastin) is used for treatment of all EXCEPT:
🔹A) Colorectal cancer
🔹B) Breast cancer
🔹C) Non-small lung cancer
🔹D) Hodgkin lymphoma
🔹✅ Answer: D
⸻
🔹Q27. Linking monoclonal antibodies to radioactive substances allows:
🔹A) Direct delivery to cancer cells
🔹B) Increased antibody synthesis
🔹C) Complement inhibition
🔹D) T-cell activation
🔹✅ Answer: A
⸻
🔹Q28. The term “magic bullet” refers to:
🔹A) Vaccination
🔹B) Specific killing of cancer cells using targeted therapy
🔹C) Gene editing
🔹D) Complement activation
🔹✅ Answer: B
⸻
🔹Q29. A monoclonal antibody that blocks TNF-α is useful in treatment of:
🔹A) RA and Crohn disease
🔹B) SLE and asthma
🔹C) Breast cancer and RA
🔹D) Hodgkin lymphoma
🔹✅ Answer: A
⸻
🔹Q30. According to the lecture, Rituximab is also used in:
🔹A) RA and SLE
🔹B) Asthma and eczema
🔹C) Type I diabetes and Graves disease
🔹D) Psoriasis and gout
🔹✅ Answer: A
⸻
🔥 Most likely Iraqi-style sneaky MCQ:
🔹A monoclonal antibody is produced from a hybridoma that survives indefinitely in culture and secretes antibodies against only one epitope. Which combination of properties made this possible?
🔹A) Activated B-cell antibody production + Myeloma immortality
🔹B) Activated T-cell cytokine production + Plasma-cell immortality
🔹C) Macrophage phagocytosis + Myeloma antibody secretion
🔹D) Plasma-cell immortality + T-cell activation
🔹✅ Answer: A
498
🔹Q1. Monoclonal antibodies are called “monoclonal” because they are derived from:
🔹A) Multiple plasma cells recognizing one antigen
🔹B) A single antibody-producing parent cell that forms a clone
🔹C) Multiple B-cell clones fused together
🔹D) A single myeloma cell
🔹✅ Answer: B
⸻
🔹Q2. The antibodies produced by cells within the same clone are:
🔹A) Similar but not identical
🔹B) Directed against different epitopes
🔹C) Exactly the same
🔹D) Both IgG and IgM
🔹✅ Answer: C
⸻
🔹Q3. The technique for producing monoclonal antibodies was discovered by:
🔹A) Ehrlich and Koch
🔹B) Jenner and Pasteur
🔹C) Kohler and Milstein
🔹D) Burnet and Medawar
🔹✅ Answer: C
⸻
🔹Q4. Kohler and Milstein received the Nobel Prize for this work in:
🔹A) 1975
🔹B) 1980
🔹C) 1984
🔹D) 1990
🔹✅ Answer: C
⸻
🔹Q5. A hybridoma is produced by fusion of:
🔹A) T cell + myeloma cell
🔹B) Plasma cell + macrophage
🔹C) Activated B cell + myeloma cell
🔹D) B cell + T cell
🔹✅ Answer: C
⸻
🔹Q6. The major advantage contributed by the myeloma cell is its ability to:
🔹A) Produce antibodies
🔹B) Grow indefinitely in culture
🔹C) Present antigen
🔹D) Secrete cytokines
🔹✅ Answer: B
⸻
🔹Q7. The myeloma cell selected for hybridoma production is chosen because it:
🔹A) Produces large amounts of antibody
🔹B) Produces IgM only
🔹C) Cannot produce antibody
🔹D) Produces complement proteins
🔹✅ Answer: C
⸻
🔹Q8. The deficient enzyme in the myeloma cell line is:
🔹A) DNA polymerase
🔹B) HGPRT
🔹C) Reverse transcriptase
🔹D) Lysozyme
🔹✅ Answer: B
⸻
🔹Q9. HGPRT deficiency makes myeloma cells unable to synthesize nucleotides from:
🔹A) Adenine and guanine
🔹B) Uracil and cytosine
🔹C) Hypoxanthine and thymidine
🔹D) ATP and GTP
🔹✅ Answer: C
⸻
🔹Q10. The main consequence of HGPRT deficiency is inability to:
🔹A) Produce proteins
🔹B) Produce antibodies
🔹C) Synthesize DNA effectively
🔹D) Undergo mitosis
🔹✅ Answer: C
⸻
🔹Q11. After dilution into microtiter wells, each well ideally contains:
🔹A) One clone
🔹B) One antigen
🔹C) One antibody molecule
🔹D) One T cell
🔹✅ Answer: A
⸻
🔹Q12. Screening of hybridomas is performed using:
🔹A) Cell nuclei
🔹B) Cell membrane fragments
🔹C) Supernatant
🔹D) DNA extract
🔹✅ Answer: C
⸻
🔹Q13. A selected hybridoma can produce monoclonal antibodies:
🔹A) For a short period only
🔹B) Until antigen disappears
🔹C) Indefinitely in culture
🔹D) Only after booster immunization
🔹✅ Answer: C
⸻
🔹Q14. A monoclonal antibody reacts with:
🔹A) All epitopes of an antigen
🔹B) Multiple antigens
🔹C) A single epitope
🔹D) All immunoglobulins
🔹✅ Answer: C
⸻
🔹Q15. Pregnancy tests use monoclonal antibodies specific for:
🔹A) α-chain of hCG
🔹B) β-chain of hCG
🔹C) LH only
🔹D) FSH only
🔹✅ Answer: B
⸻
🔹Q16. Use of β-hCG-specific monoclonal antibodies helps by:
🔹A) Increasing complement activation
🔹B) Eliminating many false-positive reactions
🔹C) Increasing hormone production
🔹D) Detecting estrogen
🔹✅ Answer: B
⸻
🔹Q17. Which is NOT listed as an in-vitro diagnostic use?
🔹A) Pregnancy testing
🔹B) Tumor antigen detection
🔹C) Hormone measurement
🔹D) Organ transplantation
🔹✅ Answer: D
⸻
🔹Q18. In the genetic engineering method, human DNA coding for antibodies is inserted into:
🔹A) Retrovirus
🔹B) Adenovirus
🔹C) Bacteriophage
🔹D) Yeast
🔹✅ Answer: C
⸻
🔹Q19. Bacteriophages are viruses that grow only inside:
🔹A) Fungi
🔹B) Human cells
🔹C) Bacteria
🔹D) Protozoa
🔹✅ Answer: C
⸻
🔹Q20. In this technique, bacteriophages carrying human genes are used with:
🔹A) Staphylococcus aureus
🔹B) Bacillus subtilis
🔹C) E. coli
🔹D) Salmonella
🔹✅ Answer: C
⸻
🔹Q21. As E. coli colonies grow, they produce:
🔹A) Human cytokines
🔹B) Human antibodies
🔹C) Human complement proteins
🔹D) Human T-cell receptors
🔹✅ Answer: B
⸻
🔹Q22. Trastuzumab (Herceptin) is directed against:
🔹A) CD20
🔹B) EGFR
🔹C) HER-2 protein
🔹D) TNF-α
🔹✅ Answer: C
⸻
🔹Q23. Trastuzumab is used in treatment of:
🔹A) Colon cancer
🔹B) Metastatic breast cancer
🔹C) RA
🔹D) Crohn disease
498
🔹Pregnancy test → means monoclonal antibodies detect the β-chain of hCG, reducing false-positive results.
🔹Tumor antigen detection → means monoclonal antibodies can be used to identify cancer markers.
🔹Hormone measurement → means monoclonal antibodies can be used to measure hormone levels accurately.
🔹Human DNA coding for antibodies inserted into bacteriophage → means the bacteriophage carries human antibody genes.
🔹Bacteriophage → means a virus that grows only inside bacteria.
🔹Bacteriophage carrying human genes used with E. coli → means the human antibody genes are transferred to the bacteria.
🔹E. coli colonies grow → means they produce human antibodies.
🔹Trastuzumab (Herceptin) → means treatment of metastatic breast cancer by targeting HER-2 protein. 🔹HER-2 protein → means a growth-promoting protein involved in some breast cancers. 🔹Rituximab (Rituxan) → means treatment of non-Hodgkin lymphoma and other B-cell malignancies. 🔹Cetuximab (Erbitux) → means treatment of colorectal cancer and head & neck cancers. 🔹Bevacizumab (Avastin) → means treatment of colorectal cancer, non-small lung cancer, and breast cancer.🔹Monoclonal antibody linked to radioactive substances → means radiation is delivered directly to cancer cells. 🔹Monoclonal antibody linked to drugs → means drugs are delivered directly to cancer cells. 🔹Magic bullet → means specific killing of cancer cells. 🔹Anti-TNF-α monoclonal antibody → means treatment of rheumatoid arthritis (RA). 🔹Anti-TNF-α monoclonal antibody → means treatment of Crohn disease. 🔹Rituximab → means treatment of rheumatoid arthritis (RA). 🔹Rituximab → means treatment of systemic lupus erythematosus (SLE).
498
🔹Q51. Which of the following is considered one of the key steps in the induction of most human cancers?
🔹A) Complement fixation on tumor cells
🔹B) Conversion of proto-oncogenes to oncogenes
🔹C) Increased IgE production
🔹D) Activation of eosinophils
🔹✅ Answer: B) Conversion of proto-oncogenes to oncogenes
⸻
🔹Q52. Conversion of proto-oncogenes to oncogenes may result from all EXCEPT:
🔹A) Mutation
🔹B) Translocation
🔹C) Amplification
🔹D) Complement fixation
🔹✅ Answer: D) Complement fixation
⸻
🔹Q53. From an immunologic perspective, cancer cells are best described as:
🔹A) Completely foreign microbial cells
🔹B) Normal cells with increased antibody production
🔹C) Altered self-cells escaping growth regulation
🔹D) Cells destroyed only by humoral immunity
🔹✅ Answer: C) Altered self-cells escaping growth regulation
⸻
🔹Q54. Tumor cells commonly display:
🔹A) Tumor-specific antigens and tumor-associated antigens
🔹B) Bacterial endotoxins only
🔹C) IgE receptors only
🔹D) Complement proteins only
🔹✅ Answer: A) Tumor-specific antigens and tumor-associated antigens
⸻
🔹Q55. Oncofetal antigens are examples of:
🔹A) Tumor-associated antigens
🔹B) Cytotoxic granules
🔹C) Immune checkpoint inhibitors
🔹D) Macrophage enzymes
🔹✅ Answer: A) Tumor-associated antigens
⸻
🔹Q56. The immune response to tumors includes all EXCEPT:
🔹A) CTL-mediated lysis
🔹B) NK-cell activity
🔹C) Macrophage-mediated tumor destruction
🔹D) IgE-mediated eosinophil killing
🔹✅ Answer: D) IgE-mediated eosinophil killing
⸻
🔹Q57. ADCC in tumor immunity means destruction mediated by:
🔹A) Antibody plus immune effector cells
🔹B) Tumor markers in serum
🔹C) Proto-oncogene amplification
🔹D) Tumor suppressor mutation
🔹✅ Answer: A) Antibody plus immune effector cells
⸻
🔹Q58. Coupling antibodies against tumor antigens with toxins or chemotherapeutic agents aims to:
🔹A) Increase toxicity mainly against normal cells
🔹B) Deliver toxic effect to tumor cells while sparing normal cells
🔹C) Suppress antigen presentation completely
🔹D) Convert tumor cells into macrophages
🔹✅ Answer: B) Deliver toxic effect to tumor cells while sparing normal cells
⸻
🔹Q59. Experimental cancer immunotherapy includes:
🔹A) Genetically engineering tumor cells to secrete cytokines
🔹B) Blocking all antigen-presenting cells
🔹C) Preventing cytokine release
🔹D) Destroying all T cells
🔹✅ Answer: A) Genetically engineering tumor cells to secrete cytokines
⸻
🔹Q60. Increasing the activity of antigen-presenting cells is mentioned as a way to:
🔹A) Decrease immune response against tumors
🔹B) Increase immune response against tumors
🔹C) Increase tumor marker secretion only
🔹D) Prevent CTL activation
🔹✅ Answer: B) Increase immune response against tumors
